Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population
Discover how we help this worldwide ultra-deep sequencing based genotyping study reveals…
Read more
Detection of in vivo hepatitis B virus surface antigen mutations—A comparison of four routine screening assays
An important requirement for a state-of-the-art hepatitis B surface antigen (HBsAg) screening…
Read more
Clinical performance of three automated screening assays for antibodies against nuclear antigens
Using a defined serum panel of patients clinically diagnosed with various CTD…
Read more
EliASymphony, the first fully automated random access assay using only recombinant human antigens and a synthetic SmDpeptide to screen for autoantibodies against extractable nuclear antigens (ENA)
Using a defined serum panel of patients clinically diagnosed with CTD as…
Read more
Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma
Learn how Cerba Research helps to evaluate the clinical performance of a…
Read more
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance
Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoringthe…
Read more
Cerba Research’s Speciality Lab in Ghent Belgium
Watch our video to find out more about Cerba Research’s speciality in…
Read more
The Added Value of Flow Cytometry in CAR T-Cell Clinical Trials Webinar
Watch Cerba Research’s latest webinar, ‘The Added Value of Flow Cytometry in…
Read more
The insights you need
Together, we can shape the future of your clinical development. Find out more about how we can support your research.